Clarity: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Lopixibat Chloride (Formerly Lum001), a Novel Apical Sodium-Dependent Bile Acid Transporter Inhibitor, in the Treatment of Primary Biliary Cirrhosis Associated with Itching

Marlyn J. Mayo, P. Pockros, David Jones, Christopher L. Bowlus, Cynthia Levy, Imran Patanwala, Bruce R. Bacon, Velimir A. Luketic, Raj Vuppalanchi, Sharon V. Medendorp,

Journal of Hepatology · 2016 · 23 citations · 0 references

Concepts